{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:20:53Z","timestamp":1789881653003,"version":"4.0.1"},"reference-count":30,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.3892\/mmr.2015.4497","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T09:16:46Z","timestamp":1446455806000},"page":"224-230","source":"Crossref","is-referenced-by-count":37,"title":["Resveratrol attenuates the progress of liver fibrosis via the Akt\/nuclear factor-\u03baB pathways"],"prefix":"10.3892","volume":"13","author":[{"given":"HUI","family":"ZHANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QINGFENG","family":"SUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TINGYAN","family":"XU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LIANG","family":"HONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RONGQUAN","family":"FU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JINGUO","family":"WU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIGUANG","family":"DING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,11,2]]},"reference":[{"key":"key20180108024525_b1-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.5858\/2007-131-1728-HSCALF","article-title":"Hepatic stellate cells and liver fibrosis","volume":"131","author":"Moreira","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"key20180108024525_b2-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"key20180108024525_b3-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/j.1478-3231.2008.01825.x","article-title":"Hepatic fibrogenesis in response to chronic liver injury: Novel insights on the role of cell-to-cell interaction and transition","volume":"28","author":"Svegliati-Baroni","year":"2008","journal-title":"Liver Int"},{"key":"key20180108024525_b4-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"key20180108024525_b5-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J Clin Invest"},{"key":"key20180108024525_b6-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis","volume":"7","author":"Friedman","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20180108024525_b7-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd2060","article-title":"Therapeutic potential of resveratrol: The in vivo evidence","volume":"5","author":"Baur","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"key20180108024525_b8-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1478-3231.2010.02295.x","article-title":"Resveratrol and liver disease: From bench to bedside and community","volume":"30","author":"Bishayee","year":"2010","journal-title":"Liver Int"},{"key":"key20180108024525_b9-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ctrv.2009.10.002","article-title":"Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma","volume":"36","author":"Bishayee","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"key20180108024525_b10-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.lfs.2013.12.011","article-title":"Potential of resveratrol in the treatment of heart failure","volume":"95","author":"Raj","year":"2014","journal-title":"Life Sci"},{"key":"key20180108024525_b11-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.intimp.2010.07.011","article-title":"Regulatory role of resveratrol on Th17 in autoimmune disease","volume":"11","author":"Petro","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"key20180108024525_b12-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.abb.2010.12.030","article-title":"The grape antioxidant resveratrol for skin disorders: Promise, prospects and challenges","volume":"508","author":"Ndiaye","year":"2011","journal-title":"Arch Biochem Biophys"},{"key":"key20180108024525_b13-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.pharep.2014.04.006","article-title":"Therapeutic potential of resveratrol in diabetic complications: In vitro and in vivo studies","volume":"66","author":"Ciddi","year":"2014","journal-title":"Pharmacol Rep"},{"key":"key20180108024525_b14-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.taap.2006.12.025","article-title":"Resveratrol: A review of preclinical studies for human cancer prevention","volume":"224","author":"Athar","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"key20180108024525_b15-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-230X-6-35","article-title":"Effect of resveratrol on alcohol-induced mortality and liver lesions in mice","volume":"6","author":"Bujanda","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"key20180108024525_b16-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.lfs.2006.11.044","article-title":"Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver","volume":"80","author":"Kasdallah-Grissa","year":"2007","journal-title":"Life Sci"},{"key":"key20180108024525_b17-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4254\/wjh.v6.i4.188","article-title":"Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease","volume":"6","author":"Heeboll","year":"2014","journal-title":"World J Hepatol"},{"key":"key20180108024525_b18-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s12272-014-0347-z","article-title":"Protective effect of resveratrol derivatives on high-fat diet induced fatty liver by activating AMP-activated protein kinase","volume":"37","author":"Choi","year":"2014","journal-title":"Arch Pharm Res"},{"key":"key20180108024525_b19-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jat.1249","article-title":"Resveratrol prevents fibrosis, NF-kappaB activation and TGF-beta increases induced by chronic CCl4 treatment in rats","volume":"28","author":"Chavez","year":"2008","journal-title":"J Appl Toxicol"},{"key":"key20180108024525_b20-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s12272-010-0415-y","article-title":"The protective effect of resveratrol on dimethylnitrosamine-induced liver fibrosis in rats","volume":"33","author":"Hong","year":"2010","journal-title":"Arch Pharm Res"},{"key":"key20180108024525_b21-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.hepres.2006.02.005","article-title":"Protective effects of resveratrol against acetaminophen-induced toxicity in mice","volume":"35","author":"Sener","year":"2006","journal-title":"Hepatol Res"},{"key":"key20180108024525_b22-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/alcalc\/agh256","article-title":"Protective effect of resveratrol on ethanol-induced lipid peroxidation in rats","volume":"41","author":"Kasdallah-Grissa","year":"2006","journal-title":"Alcohol Alcohol"},{"key":"key20180108024525_b23-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.nut.2013.11.016","article-title":"Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation","volume":"30","author":"Andrade","year":"2014","journal-title":"Nutrition"},{"key":"key20180108024525_b24-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1038\/onc.2008.300","article-title":"NF-kappaB signaling, liver disease and hepatoprotective agents","volume":"27","author":"Sun","year":"2008","journal-title":"Oncogene"},{"key":"key20180108024525_b25-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s10620-005-9031-y","article-title":"Growth arrest and decrease of alpha-SMA and type I collagen expression by palmitic acid in the rat hepatic stellate cell line PAV-1","volume":"51","author":"Abergel","year":"2006","journal-title":"Dig Dis Sci"},{"key":"key20180108024525_b26-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-\u03baB in the liver-linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20180108024525_b27-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3892\/etm.2014.1682","article-title":"NF-\u03baB inhibition alleviates carbon tetrachloride-induced liver fibrosis via suppression of activated hepatic stellate cells","volume":"8","author":"Wang","year":"2014","journal-title":"Exp Ther Med"},{"key":"key20180108024525_b28-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"472432","DOI":"10.1155\/2013\/472432","article-title":"Roles for PI3K\/AKT\/PTEN pathway in cell signaling of nonalcoholic fatty liver disease","volume":"2013","author":"Matsuda","year":"2013","journal-title":"ISRN Endocrinol"},{"issue":"Suppl 3","key":"key20180108024525_b29-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"iii70","DOI":"10.1136\/ard.2008.098459","article-title":"The PI3K\/Akt\/mTOR pathway in innate immune cells: Emerging therapeutic applications","volume":"67","author":"Weichhart","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"key20180108024525_b30-mmr-13-01-0224","doi-asserted-by":"crossref","first-page":"G1401","DOI":"10.1152\/ajpgi.00062.2008","article-title":"PI3K\/Akt activation is critical for early hepatic regeneration after partial hepatectomy","volume":"294","author":"Jackson","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2015.4497\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T23:57:20Z","timestamp":1653436640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2015.4497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,2]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,11,2]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.3892\/mmr.2015.4497"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2015.4497","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,2]]}}}